Rain, our investment in PKTX sure is looking great. Phase 1/2 clinical trials could revolutionize all organ transplants in addition to islet transplants and change treatment for uncontrolled type 1 diabetes.
In addition UBC starting experimentation for stem cell transplants is another huge opportunity.
The company is so far under the radar with such advanced technology.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.